Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

St. Vincent's Hospital, Sydney

Peter MacCallum Cancer Centre, Melbourne

Linear Clinical Research Ltd., Nedlands

Royal Hobart Hospital, Hobart

Memorial Sloan Kettering Cancer Center, New York

Montefiore Medical Center, The Bronx

Penn State Health Hershey Medical Center Cancer Institute, Hershey

Fox Chase Cancer Center, Philadelphia

Medical Oncology Hematology Consultants, Newark

Georgetown University, Washington D.C.

Virginia Cancer Specialists, Fairfax

Oncology & Hematology Associates of Southwest Virginia Inc., DBA Blue Ridge Cancer Care, Blacksburg

Levine Cancer Institute, Charlotte

University Cancer And Blood Center, Athens

Moffitt Cancer Center, Tampa

University of Alabama at Birmingham, Birmingham

Sarah Cannon Research Institute, Nashville

The Ohio State University, Columbus

Henry Ford, Detroit

University of Wisconsin, Madison

ThedaCare Regional Cancer Center, Appleton

Metro Minnesota CCOP, Saint Louis Park

Sanford Oncology Clinic, Sioux Falls

Northwestern University, Chicago

Washington University School of Medicine, St Louis

Nebraska Methodist Hospital, Omaha

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas

The University of Texas M.D. Anderson Cancer Center, Houston

University of Colorado Denver, Denver

Utah Cancer Specialists, Salt Lake City

HonorHealth, Scottsdale

Cedars-Sinai Medical Center, Los Angeles

Pacific Shores Medical Group, Huntington Beach

Compassionate Care Research Group Inc., Fountain Valley

University of California - Irvine Medical Center, Orange

Hawaii Cancer Care, Honolulu

Oregon Health and Science University, Portland

Northwest Medical Specialties, PLLC, Tacoma

Massachusetts General Hospital Cancer Center, Boston

BC Cancer, Vancouver

William Osler Health System, Brampton

Seoul National University Hospital, Seoul